- Home
- ALL vs EW Comparison
ALL vs EW Comparison
Compare ALL & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALL
- EW
- Stock Information
- Founded
- ALL 1931
- EW 1958
- Country
- ALL United States
- EW United States
- Employees
- ALL N/A
- EW N/A
- Industry
- ALL Property-Casualty Insurers
- EW Industrial Specialties
- Sector
- ALL Finance
- EW Health Care
- Exchange
- ALL Nasdaq
- EW Nasdaq
- Market Cap
- ALL 54.4B
- EW 44.8B
- IPO Year
- ALL 1993
- EW 2000
- Fundamental
- Price
- ALL $198.57
- EW $78.20
- Analyst Decision
- ALL Buy
- EW Buy
- Analyst Count
- ALL 16
- EW 20
- Target Price
- ALL $223.20
- EW $80.20
- AVG Volume (30 Days)
- ALL 1.7M
- EW 3.6M
- Earning Date
- ALL 07-30-2025
- EW 07-23-2025
- Dividend Yield
- ALL 1.99%
- EW N/A
- EPS Growth
- ALL 216.18
- EW 200.69
- EPS
- ALL 14.64
- EW 7.02
- Revenue
- ALL $65,299,000,000.00
- EW $5,522,300,000.00
- Revenue This Year
- ALL N/A
- EW $11.81
- Revenue Next Year
- ALL $8.19
- EW $9.54
- P/E Ratio
- ALL $13.76
- EW $11.14
- Revenue Growth
- ALL 11.49
- EW 8.23
- 52 Week Low
- ALL $157.50
- EW $58.93
- 52 Week High
- ALL $213.18
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- ALL 44.18
- EW 62.55
- Support Level
- ALL $190.34
- EW $72.42
- Resistance Level
- ALL $198.43
- EW $76.62
- Average True Range (ATR)
- ALL 4.16
- EW 1.46
- MACD
- ALL -0.74
- EW 0.27
- Stochastic Oscillator
- ALL 32.43
- EW 94.68
About ALL Allstate Corporation (The)
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.